Lonza Group AG (LZAGY): Among UBS' Top Tech Based Disruptive Stocks For 2030
Thermo Fisher Plant Making Astra/ Sanofi RSV Drug Reportedly Breached FDA Rules
Lonza Group AG Reports 1H Results
Lonza Welcomes New Group Chief Executive Officer Wolfgang Wienand
Acumen Pharmaceuticals Inc (ABOS) (Q1 2024) Earnings Call Transcript Highlights: Strategic ...
Earnings Call Summary | LONZA GROUP AG UNSP ADR EACH REP 0.1 ORD(LZAGY.US) Q1 2024 Earnings Conference
Q1 2024 Qualitative Update: Performance In Line With Expectations for Full-Year 2024
LONZA GROUP AG UNSP ADR EACH REP 0.1 ORD To Go Ex-Dividend On May 15th, 2024 With 0.22085 USD Dividend Per Share And 0.22085 USD Special Dividend Per Share
Lonza Prices EUR 1 Billion Straight Bond With a 3.875% Coupon
Lonza Group AG's (VTX:LONN) Largest Shareholders Are Individual Investors With 56% Ownership, Institutions Own 44%
Lonza Appoints New CEO
Swiss Healthcare Manufacturing Firm Lonza Bolsters Biologics Manufacturing Capacity With Roche's US Facility Acquisition For $1.2B
UPDATE 1-Luxury Stocks Drag European Equities Lower Ahead of Fed Meeting
UPDATE 1-Lonza to Buy Biologics Site From Roche in U.S. for $1.2 Bln
Lonza to Buy Biologics Site From Roche in U.S. for $1.2 Billion
Lonza Signs Agreement to Acquire Large-Scale Biologics Site in Vacaville (US) From Roche
Lonza Group's (VTX:LONN) Five-year Earnings Growth Trails the Favorable Shareholder Returns
Eli Lilly's Donanemab Nears Approval Decision, Could This Be a Turning Point in Alzheimer's Treatment?
Booming Weight-loss Drug Market to Lift "pick-and-shovel" Plays: Jefferies
Lonza Group AG (LZAGY) Q4 2023 Earnings Call Transcript Summary
No Data
No Data